Simon D. Campion - Jul 12, 2024 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
President, CEO & Member of BOD, Director
Signature
/s/ Dane Baumgardner, Attorney-In-Fact for Simon D. Campion
Stock symbol
XRAY
Transactions as of
Jul 12, 2024
Transactions value $
$552
Form type
4
Date filed
7/15/2024, 04:39 PM
Previous filing
Apr 15, 2024
Next filing
Sep 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +1.46K +0.5% $0.00 294K Jul 12, 2024 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Award $552 +21.4 +0.62% $25.80 3.47K Jul 12, 2024 Common Stock 21.4 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2 Includes 236 shares acquired between January 1st - June 30,2024 under the Dentsply Sirona Employee Stock Purchase Plan.
F3 Includes 272.162 shares acquired through dividend reinvestment on 4/10/2024, Includes 344.586 shares acquired through dividend reinvestment on 7/11/2024.
F4 Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.
F5 Comprised of phantom stock acquired as a result of accrued dividends.